Literature DB >> 26330618

Induction of Lung Tumors in Mice with Urethane.

Kay E Gurley1, Russell D Moser1, Christopher J Kemp1.   

Abstract

In this protocol, urethane (ethyl carbamate) is used to induce lung tumors in mice. The use of urethane as an experimental carcinogen is especially attractive as it is inexpensive, relatively safe to handle, stable, and water soluble, and the protocol involves simple intraperitoneal (i.p.) injections in young mice. Urethane typically induces bronchioalveolar adenomas and, to a lesser extent, adenocarcinomas that resemble the adenocarcinoma subtype of non-small cell lung carcinoma. On a sensitive genetic background such as A/J, mice develop multiple adenomas visible on the lung surface by 25 wk, followed by the appearance of adenocarcinomas by 40 wk. Less-sensitive strains such as B6/129 develop tumors with a longer latency.
© 2015 Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26330618     DOI: 10.1101/pdb.prot077446

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  10 in total

1.  Natural Antibodies Alert the Adaptive Immune System of the Presence of Transformed Cells in Early Tumorigenesis.

Authors:  Kavita Rawat; Shannon M Soucy; Fred W Kolling; Kiara Manohar Diaz; William T King; Anita Tewari; Claudia V Jakubzick
Journal:  J Immunol       Date:  2022-08-26       Impact factor: 5.426

2.  Nrf2-activated expression of sulfiredoxin contributes to urethane-induced lung tumorigenesis.

Authors:  Murli Mishra; Hong Jiang; Hedy A Chawsheen; Matthieu Gerard; Michel B Toledano; Qiou Wei
Journal:  Cancer Lett       Date:  2018-06-15       Impact factor: 8.679

Review 3.  Preclinical mouse solid tumour models: status quo, challenges and perspectives.

Authors:  Nicolas Gengenbacher; Mahak Singhal; Hellmut G Augustin
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

4.  FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.

Authors:  David Milewski; David Balli; Vladimir Ustiyan; Tien Le; Hendrik Dienemann; Arne Warth; Kai Breuhahn; Jeffrey A Whitsett; Vladimir V Kalinichenko; Tanya V Kalin
Journal:  PLoS Genet       Date:  2017-12-21       Impact factor: 5.917

5.  Dosimetry for lung tumorigenesis induced by urethane, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and benzo[a]pyrene (B[a]P) in A/JJmsSlc mice.

Authors:  Saeko Onami; Chigusa Okubo; Asuka Iwanaga; Hiroaki Suzuki; Hajime Iida; Yurie Motohashi; Yuki Tomonari; Seiji Otake; Hiroyuki Tsuji; Hiroyuki Yoshimura
Journal:  J Toxicol Pathol       Date:  2017-03-31       Impact factor: 1.628

6.  Preclinical, non-genetic models of lung adenocarcinoma: a comparative survey.

Authors:  Florian Janker; Walter Weder; Jae-Hwi Jang; Wolfgang Jungraithmayr
Journal:  Oncotarget       Date:  2018-07-17

7.  ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes.

Authors:  Ping Li; Jian Wang; Desheng Wu; Xiaohu Ren; Wen Wu; Ran Zuo; Qingbo Zeng; Bingyu Wang; Xi He; Jianhui Yuan; Ni Xie
Journal:  Cancer Manag Res       Date:  2019-09-02       Impact factor: 3.989

8.  Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly.

Authors:  Seung Yeob Hyun; Hye-Young Min; Ho Jin Lee; Jaebeom Cho; Hye-Jin Boo; Myungkyung Noh; Hyun-Ji Jang; Hyo-Jong Lee; Choon-Sik Park; Jong-Sook Park; Young Kee Shin; Ho-Young Lee
Journal:  J Exp Clin Cancer Res       Date:  2022-04-08

9.  Molecular characterization of ethyl carbamate toxicity in Caenorhabditis elegans.

Authors:  Jordan J Comfort; Samantha C Chomyshen; Brandon M Waddell; Hadi Tabarraei; Cheng-Wei Wu
Journal:  Toxicol Rep       Date:  2022-04-04

10.  Interleukin-6 receptor alpha and CD27 discriminate intratumoral T helper 17 subpopulations with distinct functional properties in a mouse lung cancer model.

Authors:  Chong Liu; Fei Xiong; Lingying Wang; Kang Chen; Pingshang Wu; Li Hua; Zhuo Zhang
Journal:  Immun Inflamm Dis       Date:  2021-09-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.